Bivalent BNT162b2 mRNA original/omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared with the monovalent COVID-19 booster.

Wagenhäuser I, Reusch J, Gabel A, Krone LB, Kurzai O, Petri N, Krone M (2023) Bivalent BNT162b2 mRNA original/omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared with the monovalent COVID-19 booster. Clin Microbiol Infect 29(4), 554-556.

Abstract

No abstract available

Leibniz-HKI-Authors

Oliver Kurzai

Identifier

doi: 10.1016/j.cmi.2023.01.008

PMID: 36657489